64 related articles for article (PubMed ID: 10803522)
1. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Rombouts WJ; Martens AC; Ploemacher RE
Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
[TBL] [Abstract][Full Text] [Related]
2. Murine models based on acute myeloid leukemia-initiating stem cells xenografting.
Mambet C; Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC
World J Stem Cells; 2018 Jun; 10(6):57-65. PubMed ID: 29988882
[TBL] [Abstract][Full Text] [Related]
3. Long-term engraftment of adult hematopoietic progenitors in a novel model of humanized mice.
Yu CI; Maser R; Marches F; Banchereau J; Palucka K
bioRxiv; 2023 Oct; ():. PubMed ID: 37873457
[TBL] [Abstract][Full Text] [Related]
4. Selective targeting of leukemic cell growth in vivo and in vitro using a gene silencing approach to diminish S-adenosylmethionine synthesis.
Attia RR; Gardner LA; Mahrous E; Taxman DJ; Legros L; Rowe S; Ting JP; Geller A; Kotb M
J Biol Chem; 2008 Nov; 283(45):30788-95. PubMed ID: 18753136
[TBL] [Abstract][Full Text] [Related]
5. Human Xenograft Model.
Liu S
Methods Mol Biol; 2024; 2766():9-15. PubMed ID: 38270861
[TBL] [Abstract][Full Text] [Related]
6. Sex difference feeding behaviour of NOD SCID mice in a pharmacological model of type 1 diabetes.
Tur DA; Khotskin NV; Akulov AE
J Anim Physiol Anim Nutr (Berl); 2021 Sep; 105(5):984-988. PubMed ID: 33655640
[TBL] [Abstract][Full Text] [Related]
7. Influence of donor-recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation.
Mian SA; Ariza-McNaughton L; Anjos-Afonso F; Guring R; Jackson S; Kizilors A; Gribben J; Bonnet D
Hemasphere; 2024 May; 8(5):e80. PubMed ID: 38774656
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient-derived xenografts.
Dembitz V; Durko J; Campos J; James SC; Lawson H; Kranc KR; Gallipoli P
Hemasphere; 2024 Jan; 8(1):e28. PubMed ID: 38434525
[No Abstract] [Full Text] [Related]
9. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.
Pearce DJ; Taussig D; Zibara K; Smith LL; Ridler CM; Preudhomme C; Young BD; Rohatiner AZ; Lister TA; Bonnet D
Blood; 2006 Feb; 107(3):1166-73. PubMed ID: 16234360
[TBL] [Abstract][Full Text] [Related]
10. In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice.
von Bonin M; Wermke M; Cosgun KN; Thiede C; Bornhauser M; Wagemaker G; Waskow C
PLoS One; 2013; 8(4):e60680. PubMed ID: 23585844
[TBL] [Abstract][Full Text] [Related]
11. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3.
Wunderlich M; Chou FS; Link KA; Mizukawa B; Perry RL; Carroll M; Mulloy JC
Leukemia; 2010 Oct; 24(10):1785-8. PubMed ID: 20686503
[No Abstract] [Full Text] [Related]
12. A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ.
Brassesco MS; Roberto GM; Delsin LE; Baldissera GC; Medeiros M; Umezawa K; Tone LG
Childs Nerv Syst; 2023 Jun; 39(6):1519-1528. PubMed ID: 36807999
[TBL] [Abstract][Full Text] [Related]
13. Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cells.
Mian SA; Abarrategi A; Kong KL; Rouault-Pierre K; Wood H; Oedekoven CA; Smith AE; Batsivari A; Ariza-McNaughton L; Johnson P; Snoeks T; Mufti GJ; Bonnet D
Blood Cancer Discov; 2021 Mar; 2(2):135-145. PubMed ID: 33778768
[TBL] [Abstract][Full Text] [Related]
14. Impact of the Injection Site on Growth Characteristics, Phenotype and Sensitivity towards Cytarabine of Twenty Acute Leukaemia Patient-Derived Xenograft Models.
Schueler J; Greve G; Lenhard D; Pantic M; Edinger A; Oswald E; Lübbert M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32466316
[TBL] [Abstract][Full Text] [Related]
15. Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches.
Abarrategi A; Mian SA; Passaro D; Rouault-Pierre K; Grey W; Bonnet D
J Exp Med; 2018 Mar; 215(3):729-743. PubMed ID: 29453226
[TBL] [Abstract][Full Text] [Related]
16. An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.
Her Z; Yong KSM; Paramasivam K; Tan WWS; Chan XY; Tan SY; Liu M; Fan Y; Linn YC; Hui KM; Surana U; Chen Q
J Hematol Oncol; 2017 Oct; 10(1):162. PubMed ID: 28985760
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia.
Liu FR; Jin H; Wang Y; Chen C; Li M; Mao SJ; Wang Q; Li H
Drug Deliv; 2017 Nov; 24(1):882-890. PubMed ID: 28574300
[TBL] [Abstract][Full Text] [Related]
18. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
[TBL] [Abstract][Full Text] [Related]
19. Biology and relevance of human acute myeloid leukemia stem cells.
Thomas D; Majeti R
Blood; 2017 Mar; 129(12):1577-1585. PubMed ID: 28159741
[TBL] [Abstract][Full Text] [Related]
20. Translating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity.
Yanagisawa B; Ghiaur G; Smith BD; Jones RJ
Exp Hematol; 2016 Dec; 44(12):1130-1137. PubMed ID: 27693555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
